Bone formation by human paediatric marrow stromal cells in a functional allogeneic immune system
In this study, we employed an immunodeficient animal model humanised with allogeneic immune cells to study the immune responses towards chondrogenically differentiated human pediatric MSCs (ch-pMSCs). We show that ch-differentiated pMSCs remained non-immunogenic to allogeneic CD4 and CD8 T cells in an in vitro co-culture model. After subcutaneous implantation in mice, ch-pMSC-derived grafts were able to initiate bone mineralisation in the presence of an allogeneic immune system for 3 weeks without the onset of immune responses. Re-exposing the splenocytes of the humanised animals to pMSCs did not trigger further T cell proliferation, suggesting an absence of secondary immune responses. Moreover, ch-pMSCs generated mature bone after 8 weeks of implantation that persisted for up to 6 more weeks in the presence of an allogeneic immune system. These data collectively show that human allogeneic chondrogenically differentiated pediatric MSCs might be a safe and potent option for bone defect repair in the tissue engineering and regenerative medicine setting.PMID:38377846 | DOI:10.1016/j.biomaterials.2024.122471
Source: Biomaterials - Category: Materials Science Authors: Virginia Palomares Cabeza Niamh Fahy Caoimhe H Kiernan Andrea Lolli Janneke Witte-Bouma Shorouk Fahmy Garcia Ana Merino Nicole Kops Yanto Ridwan Eppo B Wolvius Pieter A J Brama Martin J Hoogduijn Eric Farrell Source Type: research
More News: Bone Graft | Gastroschisis Repair | Materials Science | Pediatrics | Stem Cell Therapy | Stem Cells | Study